Sharekhan

IOL Chemicals and Pharmaceuticals Ltd

Fri 22/05/2026,0:0:0 | NSE : IOLCP

₹ 118.730.00 (0.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 121.05

Previous Close

₹ 118.73

Volume

5829302

Mkt Cap ( Rs. Cr)

₹3485.05

High

₹ 124.40

Low

₹ 118.21

52 Week High

₹ 126.72

52 Week Low

₹ 67.19

Book Value Per Share

₹ 60.37

Dividend Yield

0.84

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on IOL Chemicals and Pharmaceuticals Ltd

Your Vote -

Buy

62.95%

Hold

1.92%

Sell

35.13%

62.95%

780 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

28%

Sell Order Quantity

72%

Bid Price

Qty

119.72

21

120.00

123

120.00

344

120.00

60

120.00

358

Bid Total

152168

Bid Price

Qty

119.95

690

120.00

76

120.00

524

120.00

18

120.00

666

Bid Total

388881

Option Chain

Analyzes market sentiment, predicts IOL Chemicals and Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • IOL Chem. & Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    22 May 2026, 5:59PM Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q4 FY2026
  • IOL Chem. & Pharma. - Analysts/Institutional Investor Meet/Con. Call Updates

    22 May 2026, 5:52PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Schedule of meet
  • IOL Chem. & Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 May 2026, 5:49PM Schedule of Analyst/Investor Meeting
  • IOL Chem. & Pharma. - Analysts/Institutional Investor Meet/Con. Call Updates

    22 May 2026, 5:45PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Link of Recording
  • IOL Chem. & Pharma. - Investor Presentation

    21 May 2026, 5:52PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Investor Presentation
  • IOL Chem. & Pharma. - Copy of Newspaper Publication

    21 May 2026, 4:59PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • IOL Chem. & Pharma. - Announcement under Regulation 30 (LODR)-Investor Presentation

    21 May 2026, 5:56PM Investor Presentation
  • IOL Chem. & Pharma. - Press Release

    20 May 2026, 7:47PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 20, 2026, titled ""Press Release Financial R
  • IOL Chem. & Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    20 May 2026, 6:38PM Press Release: Financial Results for the quarter and year ended 31st March 2026
  • IOL Chem. & Pharma. - Comments Of Board Of Directors

    20 May 2026, 6:33PM Comments of Board of Directors
  • IOL Chem. & Pharma. - General Updates

    20 May 2026, 3:23PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Fixed date of 39th Annual General Meeting of the Company and Book Closure o
  • IOL Chem. & Pharma. - Fixed 39Th Annual General Meeting Of The Company And Book Closure Of Register Of Members

    20 May 2026, 3:23PM Fixed 39th Annual General Meeting of the Company and Book Closure of Register of Members
  • IOL Chem. & Pharma. - Outcome of Board Meeting

    20 May 2026, 2:32PM IOL Chemicals and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • IOL Chem. & Pharma. Q4 net profit jumps 68.18% at Rs 53.18 cr

    20 May 2026, 2:50PM The company reported standalone net profit of Rs 53.18 crore for the quarter ended March 31, 2026 as compared to Rs 31.62 crore in the same period las
  • IOL Chem. & Pharma. - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Audited Financial Results For

    20 May 2026, 2:40PM Outcome of the Board Meeting and submission of Audited Financial Results for the quarter and year ended 31st March 2026
  • IOL Chem. & Pharma. - Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended

    20 May 2026, 2:36PM Outcome of Board Meeting and submission of Audited Financial Results
  • IOL Chem. & Pharma. - Analysts/Institutional Investor Meet/Con. Call Updates

    18 May 2026, 6:46PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Schedule of meet
  • IOL Chem. & Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 May 2026, 6:45PM Schedule of analyst / investor conference call - Q4 FY26
  • IOL Chem. & Pharma. - Board Meeting Intimation for Notice Of The Board Meeting

    13 May 2026, 4:35PM IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia,
  • IOL Chem. & Pharma. - Spurt in Volume

    12 May 2026, 10:24AM Significant increase in volume has been observed in IOL Chemicals and Pharmaceuticals Limited. The Exchange, in order to ensure that investors have la
  • IOL Chem. & Pharma. - Spurt in Volume

    11 May 2026, 6:16PM Significant increase in volume has been observed in IOL Chemicals and Pharmaceuticals Limited. The Exchange, in order to ensure that investors have la
  • IOL Chem. & Pharma. - General Updates

    9 May 2026, 4:21PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about General Updates
  • IOL Chem. & Pharma. - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And D

    9 May 2026, 4:13PM Disclosure under regulation 39 of Sexurities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations,2015
  • IOL Chem. & Pharma. - Disclosure under SEBI Takeover Regulations

    4 May 2026, 7:38PM ÿVarinder Guptaÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial A
  • IOL Chem. & Pharma. - Structural Digital Database

    17 Apr 2026, 5:49PM Compliance certificate for the quarter ended 31st March 2026 with regard to Structured Digital Database SDD
  • IOL Chem. & Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    15 Apr 2026, 5:20PM As of March 2026, 57.48% is owned by Indian Promoters and 42.52% by Public. <p align=justify> Top four Promoters holding highest number of shares of I
  • IOL Chem. & Pharma. - Copy of Newspaper Publication

    13 Apr 2026, 3:27PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • IOL Chem. & Pharma. - Copy of Newspaper Publication

    10 Apr 2026, 12:41PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • IOL Chem. & Pharma. - General Updates

    9 Apr 2026, 3:02PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about General Updates
  • IOL Chem. & Pharma. - Disclosure Under Regulation 30 - Participation In 'Saksham Niveshak' Campaign

    9 Apr 2026, 2:59PM Disclosure under Regulation 30
  • IOL Chem. & Pharma. - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    4 Apr 2026, 1:29PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • IOL Chem. & Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    4 Apr 2026, 1:25PM Compliance Certificate under Regulation 74
  • IOL Chem. & Pharma. - General Updates

    1 Apr 2026, 4:27PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about General Updates
  • IOL Chem. & Pharma. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulation

    1 Apr 2026, 4:31PM Intimation under Regulation 30
  • IOL Chem. & Pharma. - Trading Window

    26 Mar 2026, 11:16AM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trad
  • IOL Chem. & Pharma. - Updates

    20 Mar 2026, 1:03PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under SEBI (Prohibition of Insider Trading Regulation), 201
  • IOL Chem. & Pharma. - Disclosure Under SEBI (Prohibition Of Insider Trading Regulation), 2015

    20 Mar 2026, 12:59PM Disclosure under SEBI (PIT) Regulations
  • IOL Chem. & Pharma. - Updates

    19 Mar 2026, 4:18PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under SEBI (Prohibition of Insider Trading Regulation), 2015
  • IOL Chem. & Pharma. - Updates

    19 Mar 2026, 3:47PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under SEBI (Prohibition of Insider Trading Regulation), 201
  • IOL Chem. & Pharma. - Disclosure Under SEBI (Prohibition Of Insider Trading Regulation), 2015

    19 Mar 2026, 4:14PM Disclosure under SEBI (PIT) Regulations
  • IOL Chem. & Pharma. - Disclosure Under SEBI (Prohibition Of Insider Trading Regulation), 2015

    19 Mar 2026, 3:40PM Disclosure under SEBI (PIT) Regulations
  • IOL Chem. & Pharma. - Updates

    18 Mar 2026, 3:16PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under SEBI (Prohibition of Insider Trading Regulation), 2015
  • IOL Chem. & Pharma. - Updates

    18 Mar 2026, 3:02PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under SEBI (Prohibition of Insider Trading Regulation), 2015
  • IOL Chem. & Pharma. - Disclosure Under SEBI (Prohibition Of Insider Trading Regulation), 2015

    18 Mar 2026, 3:13PM Disclosure under SEBI (PIT) Regulations
  • IOL Chem. & Pharma. - Disclosure Under SEBI (Prohibition Of Insider Trading Regulation), 2015

    18 Mar 2026, 2:55PM Disclosure under SEBI (PIT) Regulations
  • IOL Chem. & Pharma. - Reply to Clarification- Financial results

    17 Mar 2026, 12:22PM The Exchange had sought clarification from IOL Chemicals and Pharmaceuticals Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 o
  • IOL Chem. & Pharma. - Clarification - Financial Results

    11 Mar 2026, 12:43PM The Exchange has sought clarification from IOL Chemicals and Pharmaceuticals Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 o
  • IOL Chem. & Pharma. - General Updates

    6 Mar 2026, 3:53PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about General Updates
  • IOL Chem. & Pharma. - EDQM Issued CEP Certificate For 'METFORMIN HYDROCHLORIDE Process-II'

    6 Mar 2026, 3:59PM CEP Certificate for \METFORMIN HYDROCHLORIDE Process-II\
  • IOL Chem. & Pharma. - Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regu

    2 Mar 2026, 7:02PM Disclosure pursuant to Regulation 30
  • IOL Chem. & Pharma. - General Updates

    2 Mar 2026, 6:57PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about General Updates
  • IOL Chemicals and Pharmaceuticals

    16 Jun 2025 , 9:19AM IOL Chemicals: The company’s product Acetic Anhydride has been registered with REACH in accordance with EU REACH regulation on chemicals and their safe use. This certification allows the company to export Acetic Anhydride across all the countries in the European Union.
  • IOL Chemicals and Pharmaceuticals

    30 Dec 2024 , 11:54AM The board approved the subdivision of each share into five.
  • IOL Chemicals

    30 May 2023 , 10:13AM Controller of Patent, Indian Patent Office, Government of India has granted on 29th May 2023 a Patent for invention entitled process for the preparation of carcinogenic azido impurities free losartan and salts thereof. Losartan is a drug used for treatment of hypertension. Positive read through for the stock.
  • IOL Chemicals gets European drug regulator nod to export Paracetamol

    8 May 2023 , 1:48PM IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to Export in European market
  • IOL Chem gets patent for preparation of Sartan drugs of Formula I

    24 Nov 2022 , 11:42AM Sartan Drugs are used to treat high blood pressure and heart failure

Key fundamentals

Evaluate the intrinsic value of IOL Chemicals and Pharmaceuticals Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 1930.38 1804.45 1644.09 1586.18 1433.02
Liabilities 1930.38 1804.45 1644.09 1586.18 1433.02
Equity 58.71 58.71 58.71 58.71 58.71
Gross Profit 269.09 202.17 231.52 226.52 256.28
Net Profit 137.72 101 135.42 139.98 165.66
Cash From Operating Activities 214.42 178.68 290.76 123.14 91.04
NPM(%) 5.93 4.85 6.34 6.31 7.58
Revenue 2319.06 2079.21 2132.79 2217.11 2184.02
Expenses 2049.97 1877.04 1901.27 1990.59 1927.74
ROE(%) 7.77 5.7 7.64 7.9 9.34

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
17 Feb 2026 1 50 0.84 75.3
18 Feb 2025 4 40 0.84 356.7
16 Feb 2024 5 50 0.84 443.15
17 Feb 2023 4 40 0.84 325.4
15 Feb 2022 4 40 0.84 447.9
08 Sep 2021 2 20 0.84 700.85
17 Nov 2020 4 40 0.84 691.55
18 Mar 2020 3 30 0.84 232.75

Peers

Other companies within the same industry or sector that are comparable to IOL Chemicals and Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1420.85 5.34 13.27 107.85 1071.07 0.00
Sharda Cropchem Ltd 893.10 -1.47 11.83 1071.73 754.66 1.68
Amines and Plasticizers Ltd 190.60 0.00 30.84 653.58 372.61 0.26
Indogulf Cropsciences Ltd 61.62 -0.76 10.20 579.54 49.78 0.00

Company Info

2003 -Shareholders approved the delisting of equity shares of the company from Ludhiana and Delhi Stock Exchanges. -Increase in Authorised Capital of the Company from Rs 150 million to Rs 200 million. 2004 -Industrial Organics Ltd has informed that after the resignation of Shri N C Gupta, Chairman cum Director, Shri Varinder Gupta, Managing Director of the Company has been appointed as Chairman of the Board of Directors. 2007 - Company name has been changed from Industrial Organics Limited to IOL Chemicals and Pharmaceuticals Ltd. 2008 -IOL Chemicals & Pharmaceuticals has been granted a Certificate of Registration by BSI Management System, for Quality Management System ISO 9001:2000 and for Environment Management System / 14001:2004 -IOL Chemicals has received accreditation certificate of foreign drug manufacture from the Ministry of Health, Labor and Welfare, Yoichi Masuzoe, Japan enabling the Company to export its bulk drugs, Ibuprofen in Japan. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2008 (Second prize in chemical sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources. 2009 -Sh. Parminder Singh Cheema has been appointed as Nominee Director on the Board of the Company -IOL Chemicals announced the commencement of its manufacturing operations of Mono-chloro Acetic Acid (MCA) and Acetyl Chloride at its new manufacturing units with capacities of 7200 TPA and 5200 TPA respectively, -IOL Chemicals has received DMF acknowledgement letter for ibuprofen from Health Canada, Therapeutic Products Directorate, Canada, the drug regulatory body of Canada to enable it to export ibuprofen in that country. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2009 (second rank in Drugs & Pharmaceuticals Sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources of the country. -IOL Chemicals and Pharmaceuticals felicitated by PEDA for Energy Conservation 2010 -IOL Chemicals has obtained a Certificate of Suitability for its manufacturing facilities for Ibuprofen from European Directorate for the Quality of Medicines and HealthCare. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2010 2011 -IOL Chemicals's In-House Research & Development Unit has got successfully recognition from DSIR (Deptt. of Scientific & Industrial Research), Ministry of Science & Technology, New Delhi. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2011 2012 -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2012 2013 -IOL Chemicals & Pharmaceuticals won "National Energy Conservation award (Drug and Pharma sector)2013" 2014 -IOL Chemicals & Pharmaceuticals Ltd. won "National Energy Conservation Award 2014". 2015 -IOLCP to launch API business in US market -IOL Chemicals completes De-bottlenecking project 2020 -IOL Chemicals and Pharmaceuticals Ltd got EUGMP Certification from National Institute of Pharmacy and Nutrition 2021 - IOL Chemicals and Ph Approval Of Korean Ministry Of Food And Drug Safety (Korean FDA) For Company'S API Products 'Ibuprofen 2024 -Indian Chemical Council (ICC) awarded Responsible Care Logo to the Company. -IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'National Medical Products Administration (NMPA), China approves Fenofibrate manufactured by the Company. 2025-IOL Awarded EcoVadis Silver Medal - Ranks Among the Top 15% companies globally.-The Company has splits its face value from Rs. 10/- to Rs. 2/-.

2003 -Shareholders approved the delisting of equity shares of the company from Ludhiana and Delhi Stock Exchanges. -Increase in Authorised Capital of the Company from Rs 150 million to Rs 200 million. 2004 -Industrial Organics Ltd has informed that after the resignation of Shri N C Gupta, Chairman cum Director, Shri Varinder Gupta, Managing Director of the Company has been appointed as Chairman of the Board of Directors. 2007 - Company name has been changed from Industrial Organics Limited to IOL Chemicals and Pharmaceuticals Ltd. 2008 -IOL Chemicals & Pharmaceuticals has been granted a Certificate of Registration by BSI Management System, for Quality Management System ISO 9001:2000 and for Environment Management System / 14001:2004 -IOL Chemicals has received accreditation certificate of foreign drug manufacture from the Ministry of Health, Labor and Welfare, Yoichi Masuzoe, Japan enabling the Company to export its bulk drugs, Ibuprofen in Japan. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2008 (Second prize in chemical sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources. 2009 -Sh. Parminder Singh Cheema has been appointed as Nominee Director on the Board of the Company -IOL Chemicals announced the commencement of its manufacturing operations of Mono-chloro Acetic Acid (MCA) and Acetyl Chloride at its new manufacturing units with capacities of 7200 TPA and 5200 TPA respectively, -IOL Chemicals has received DMF acknowledgement letter for ibuprofen from Health Canada, Therapeutic Products Directorate, Canada, the drug regulatory body of Canada to enable it to export ibuprofen in that country. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2009 (second rank in Drugs & Pharmaceuticals Sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources of the country. -IOL Chemicals and Pharmaceuticals felicitated by PEDA for Energy Conservation 2010 -IOL Chemicals has obtained a Certificate of Suitability for its manufacturing facilities for Ibuprofen from European Directorate for the Quality of Medicines and HealthCare. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2010 2011 -IOL Chemicals's In-House Research & Development Unit has got successfully recognition from DSIR (Deptt. of Scientific & Industrial Research), Ministry of Science & Technology, New Delhi. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2011 2012 -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2012 2013 -IOL Chemicals & Pharmaceuticals won "National Energy Conservation award (Drug and Pharma sector)2013" 2014 -IOL Chemicals & Pharmaceuticals Ltd. won "National Energy Conservation Award 2014". 2015 -IOLCP to launch API business in US market -IOL Chemicals completes De-bottlenecking project 2020 -IOL Chemicals and Pharmaceuticals Ltd got EUGMP Certification from National Institute of Pharmacy and Nutrition 2021 - IOL Chemicals and Ph Approval Of Korean Ministry Of Food And Drug Safety (Korean FDA) For Company'S API Products 'Ibuprofen 2024 -Indian Chemical Council (ICC) awarded Responsible Care Logo to the Company. -IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'National Medical Products Administration (NMPA), China approves Fenofibrate manufactured by the Company. 2025-IOL Awarded EcoVadis Silver Medal - Ranks Among the Top 15% companies globally.-The Company has splits its face value from Rs. 10/- to Rs. 2/-.

Parent Organisation

IOL Chemicals and Pharmaceuticals Ltd.

Founded

29/09/1986

Managing Director

Mr.Varinder Gupta

NSE Symbol

IOLCPEQ

FAQ

OPEN FREE* DEMAT ACCOUNT